Paper39655194
Myriad factors and pathways influencing tumor radiotherapy resistance.
Mi L and 1 other. Open Life Sci, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Myriad factors and pathways influencing tumor radiotherapy resistance. Papers, record 39655194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39655194
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References237
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36316397 | Dynamic alternative DNA structures in biology and disease. | Nat Rev Genet | 2023 | https://conductscience.org/library/papers/36316397 | PubMed |
| 2 | 33597271 | Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33597271 | PubMed |
| 3 | 26993419 | To live or let die: Unclear task of autophagy in the radiosensitization battle. | Radiother Oncol | 2016 | https://conductscience.org/library/papers/26993419 | PubMed |
| 4 | 28134023 | Effects of ionizing radiation on DNA methylation: from experimental biology to clinical applications. | Int J Radiat Biol | 2017 | https://conductscience.org/library/papers/28134023 | PubMed |
| 5 | 29658569 | β‑catenin nuclear translocation induced by HIF‑1α overexpression leads to the radioresistance of prostate cancer. | Int J Oncol | 2018 | https://conductscience.org/library/papers/29658569 | PubMed |
| 6 | 36333630 | NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer. | Apoptosis | 2023 | https://conductscience.org/library/papers/36333630 | PubMed |
| 7 | 34508258 | The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. | Nat Rev Clin Oncol | 2022 | https://conductscience.org/library/papers/34508258 | PubMed |
| 8 | 31276435 | SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed. | Autophagy | 2019 | https://conductscience.org/library/papers/31276435 | PubMed |
| 9 | 22258607 | The DNA damage response and cancer therapy. | Nature | 2012 | https://conductscience.org/library/papers/22258607 | PubMed |
| 10 | 25615283 | Experimental phase diagram of negatively supercoiled DNA measured by magnetic tweezers and fluorescence. | Nanoscale | 2015 | https://conductscience.org/library/papers/25615283 | PubMed |
| 11 | 26122185 | Opportunities and challenges of radiotherapy for treating cancer. | Nat Rev Clin Oncol | 2015 | https://conductscience.org/library/papers/26122185 | PubMed |
| 12 | 37423560 | Co-targeting autophagy and NRF2 signaling triggers mitochondrial superoxide to sensitize oral cancer stem cells for cisplatin-induced apoptosis. | Free Radic Biol Med | 2023 | https://conductscience.org/library/papers/37423560 | PubMed |
| 13 | 22770212 | Cancer epigenetics: from mechanism to therapy. | Cell | 2012 | https://conductscience.org/library/papers/22770212 | PubMed |
| 14 | 25033211 | Elevated levels of G-quadruplex formation in human stomach and liver cancer tissues. | PLoS One | 2014 | https://conductscience.org/library/papers/25033211 | PubMed |
| 15 | 32459988 | Biomarker-Guided Development of DNA Repair Inhibitors. | Mol Cell | 2020 | https://conductscience.org/library/papers/32459988 | PubMed |
| 16 | 33945288 | Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/33945288 | PubMed |
| 17 | 28619042 | Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28619042 | PubMed |
| 18 | 36522816 | Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36522816 | PubMed |
| 19 | 30465162 | Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment. | Cancer Metastasis Rev | 2018 | https://conductscience.org/library/papers/30465162 | PubMed |
| 20 | 28302823 | PARP inhibitors: Synthetic lethality in the clinic. | Science | 2017 | https://conductscience.org/library/papers/28302823 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935534 | Definitive radiotherapy versus surgery after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score-matched study of efficacy and safety. | Front Oncol | 2026 | https://conductscience.org/library/papers/42935534 | PubMed |
| 42749398 | mRNA-based therapeutics in lung Cancer: Mechanisms, applications, and translational challenges. | J Genet Eng Biotechnol | 2026 | https://conductscience.org/library/papers/42749398 | PubMed |
| 42465745 | Tumor-associated macrophages: potential therapeutic strategies and future prospects in radioresistance of cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42465745 | PubMed |
| 41726230 | Ferroptosis and immunity: rewiring the tumor microenvironment for therapy. | RSC Adv | 2026 | https://conductscience.org/library/papers/41726230 | PubMed |
| 41656818 | [Mechanistic research progress on radiotherapy resistance of cancer stem cells]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | https://conductscience.org/library/papers/41656818 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39655194
GET https://conductscience.org/api/papers/v1/39655194/references?page=2